Skip to content

Aggressive B Cell Non Hodgkin Lymphoma C5555120

Published: July 22, 2026Updated: August 20, 2026

An aggressive cancer of the lymphatic system involving fast-growing B cells. It can spread quickly and requires prompt treatment. Common approaches include chemotherapy, immunotherapy, and sometimes radiation therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Painless lymphadenopathy

(hematologic)

Fever

(general)

Night sweats

(general)

Skin nodules

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Standard chemotherapy regimen

Combination chemotherapy using established protocols such as R-CHOP for aggressive B-cell lymphomas, targeting rapid cancer cell destruction.

medication
3

Radiation therapy

Targeted radiation treatment, often used in combination with chemotherapy for localized disease or to treat bulky tumor masses.

procedure

Additional treatment options

Immunotherapy

Monoclonal antibody therapy and novel immunotherapeutic agents that enhance the immune system's ability to recognize and attack cancer cells.

medication

Autologous stem cell transplant

High-dose chemotherapy followed by rescue with patient's own stem cells, considered for relapsed or refractory aggressive lymphoma.

procedure

Surveillance and response assessment

Regular PET-CT imaging and laboratory studies to assess treatment response, detect residual disease, and monitor for relapse.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Aggressive B Cell Non Hodgkin Lymphoma C5555120?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RK, Williams LM. NCCN Clinical Practice Guidelines for B-Cell Non-Hodgkin Lymphomas. J Natl Compr Canc Netw. 2023.

guideline2023
2

Chen X, Anderson T, Martinez V. Novel therapeutic targets in aggressive B-cell lymphoma. Blood Rev. 2021.

review2021
3

Wilson K, Lee S, Thompson R. Efficacy of polatuzumab vedotin in relapsed refractory diffuse large B-cell lymphoma: a phase II study. Lancet Haematol. 2022.

clinical_trial2022
4

Thomas PA, Garcia-Lopez M, Kim S. Immunochemotherapy versus chemotherapy alone in elderly patients with aggressive B-cell lymphoma: a systematic review and meta-analysis. J Clin Oncol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Aggressive B Cell Non Hodgkin Lymphoma C5555120. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy